{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:14:49Z","timestamp":1760660089107,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.plefa.2022.102414","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T21:37:18Z","timestamp":1647553038000},"page":"102414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Plasma and red blood cell n3 fatty acids correlate positively with the WISC-R verbal and full-scale intelligence quotients and inversely with Conner's parent-rated ADHD index t-scores in children with high functioning autism and Asperger's syndrome"],"prefix":"10.1016","volume":"178","author":[{"given":"Beata Joanna","family":"Kozielec - Oracka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoeju","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amritpal S.","family":"Bhullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Stasiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6264-1044","authenticated-orcid":false,"given":"Kebreab","family":"Ghebremeskel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.plefa.2022.102414_bib0001","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10803-007-0364-6","article-title":"Asperger syndrome and autism: a comparative longitudinal follow-up study more than 5 years after original diagnosis","volume":"38","author":"Cederlund","year":"2008","journal-title":"J. Autism Dev. Disord."},{"issue":"5","key":"10.1016\/j.plefa.2022.102414_bib0002","doi-asserted-by":"crossref","first-page":"349","DOI":"10.18869\/nirp.bcn.8.5.349","article-title":"Behavioral, cognitive and neural markers of asperger syndrome","volume":"8","author":"Faridi","year":"2017","journal-title":"Basic Clin. Neurosci. J."},{"issue":"4","key":"10.1016\/j.plefa.2022.102414_bib0003","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10803-017-3042-3","article-title":"Examining the behavioural sleep-wake rhythm in adults with autism spectrum disorder and no comorbid intellectual disability","volume":"47","author":"Baker","year":"2017","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.plefa.2022.102414_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.rasd.2015.09.007","article-title":"Assessment of feeding problems in children with an autism spectrum disorder","volume":"21","author":"Aponte","year":"2016","journal-title":"Res. Autism Spectr. Disord."},{"issue":"6","key":"10.1016\/j.plefa.2022.102414_bib0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.pedn.2013.01.008","article-title":"Eating behaviors, diet quality, and gastrointestinal symptoms in children with autism spectrum disorders: a brief review","volume":"28","author":"Kral","year":"2013","journal-title":"J. Pediatr. Nurs."},{"issue":"7","key":"10.1016\/j.plefa.2022.102414_bib0006","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10803-011-1367-x","article-title":"Depression symptoms in boys with autism spectrum disorder and comparison samples","volume":"42","author":"Gadow","year":"2012","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.plefa.2022.102414_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rasd.2016.07.003","article-title":"The comorbidity of ADHD in children diagnosed with autism spectrum disorder","volume":"31","author":"Stevens","year":"2016","journal-title":"Res. Autism Spectr. Disord."},{"issue":"12","key":"10.1016\/j.plefa.2022.102414_bib0008","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s10803-014-2170-2","article-title":"Psychiatric comorbidity and medication use in adults with autism spectrum disorder","volume":"44","author":"Buck Buck","year":"2014","journal-title":"J. Autism Dev. Disord."},{"issue":"6","key":"10.1016\/j.plefa.2022.102414_bib0009","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00213-013-3263-x","article-title":"Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study","volume":"231","author":"Hsia","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.plefa.2022.102414_bib0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10803-016-2946-7","article-title":"Psychotropic medication use among insured children with autism spectrum disorder","volume":"47","author":"Madden","year":"2017","journal-title":"J. Autism Dev. Disord."},{"issue":"1","key":"10.1016\/j.plefa.2022.102414_bib0011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1088357614523121","article-title":"Supporting students with asperger syndrome on college campuses: current practices","volume":"31","author":"Barnhill","year":"2016","journal-title":"Focus Autism Dev. Disabil."},{"issue":"1","key":"10.1016\/j.plefa.2022.102414_bib0012","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/1467-8578.12125","volume":"43","author":"Peters","year":"2016","journal-title":"Br. J. Spec. Educ."},{"issue":"10","key":"10.1016\/j.plefa.2022.102414_bib0013","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s10803-006-0343-3","article-title":"Social skills training group for adolescents with Asperger syndrome and high-functioning autism","volume":"37","author":"Tse","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.plefa.2022.102414_bib0014","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3945\/jn.109.119578","article-title":"Serum phospholipid docosahexaenoic acid is associated with cognitive functioning during middle adulthood","volume":"140","author":"Muldon","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.plefa.2022.102414_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/CIA.S5231","article-title":"Omega-3 fatty acids: potential role in the management of early Alzheimer's disease","volume":"5","author":"Jicha","year":"2010","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.plefa.2022.102414_bib0016","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1542\/peds.2009-3277","article-title":"Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: ryukyus child health study","volume":"126","author":"Murakami","year":"2010","journal-title":"Paediatrics"},{"issue":"1","key":"10.1016\/j.plefa.2022.102414_bib0017","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jn\/131.1.118","article-title":"Dietary fatty acid composition in pregnancy alter neurite membrane fatty acids and dopamine in newborn rat brain","volume":"131","author":"Innis","year":"2001","journal-title":"J. Nutr."},{"issue":"4","key":"10.1016\/j.plefa.2022.102414_bib0018","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11745-003-1081-1","article-title":"Enhancement of G protein-coupled signalling by DHA phospholipids","volume":"38","author":"Mitchell","year":"2003","journal-title":"Lipids"},{"issue":"4","key":"10.1016\/j.plefa.2022.102414_bib0019","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1471-4159.2004.02520.x","article-title":"Docosahexaenoic acid promotes neurite growth in hippocampal neurons","volume":"90","author":"Calderon","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plefa.2022.102414_bib0020","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11064-008-9845-z","article-title":"Docosahexaenoic acid significantly stimulates immediate early response genes and neurite outgrowth","volume":"34","author":"Dagai","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.plefa.2022.102414_bib0021","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.neurobiolaging.2008.05.027","article-title":"Omega 3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurons throughout development and in aged animals","volume":"3","author":"Robson","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.plefa.2022.102414_bib0022","doi-asserted-by":"crossref","first-page":"e24777","DOI":"10.1371\/journal.pone.0024777","article-title":"Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease","volume":"6","author":"Astarita","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.plefa.2022.102414_bib0023","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.plefa.2022.102414_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147129","article-title":"Alterations in lipid and inositol metabolisms in two dopaminergic disorders","volume":"11","author":"Schulte","year":"2016","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"10.1016\/j.plefa.2022.102414_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2012.09.041","article-title":"Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis","volume":"207","author":"Hoen","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.plefa.2022.102414_bib0026","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2010.03.018","article-title":"A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression","volume":"68","author":"Lin","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2022.102414_bib0027","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.psyneuen.2017.10.005","article-title":"Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders","volume":"87","author":"Thesing","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.plefa.2022.102414_bib0028","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2891-7-8","article-title":"Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study","volume":"7","author":"Colter","year":"2008","journal-title":"Nutr. J."},{"issue":"6","key":"10.1016\/j.plefa.2022.102414_bib0029","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cpr.2014.05.005","article-title":"Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials","volume":"34","author":"Hawkey","year":"2014","journal-title":"Clin. Psychol Rev."},{"issue":"5","key":"10.1016\/j.plefa.2022.102414_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156432","article-title":"Omega-3 and omega-6 polyunsaturated fatty acid levels and correlations with symptoms in children with attention deficit hyperactivity disorder, autistic spectrum disorder and typically developing controls","volume":"11","author":"Parletta","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.plefa.2022.102414_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/plef.2001.0281","article-title":"Plasma fatty acid levels in autistic children","volume":"65","author":"Vancassel","year":"2001","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.plefa.2022.102414_bib0032","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nut.2013.03.009","article-title":"Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism","volume":"29","author":"Al-Farsi","year":"2013","journal-title":"Nutrition"},{"issue":"5","key":"10.1016\/j.plefa.2022.102414_bib0033","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.3390\/ijms160510061","article-title":"Autistic children exhibit decreased levels of essential fatty acids in red blood cells","volume":"16","author":"Brigandi","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plefa.2022.102414_bib0034","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12993-014-0048-2","article-title":"Reduced levels of plasma polyunsaturated fatty acids and serum carnitine in autistic children: relation to gastrointestinal manifestations","volume":"11","author":"Mostafa","year":"2015","journal-title":"Behav. Brain Funct."},{"issue":"4","key":"10.1016\/j.plefa.2022.102414_bib0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nut.2015.10.019","article-title":"Abnormal fatty acids in Canadian children with autism","volume":"32","author":"Jory","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.plefa.2022.102414_bib0036","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neulet.2015.11.006","article-title":"Down-regulation of a signaling mediator in association with lowered plasma arachidonic acid levels in individuals with autism spectrum disorders","volume":"610","author":"Yui","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.plefa.2022.102414_bib0037","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.plefa.2013.03.008","article-title":"Omega-3 fatty acids are related to abnormal emotion processing in adolescent boys with attention deficit hyperactivity disorder","volume":"88","author":"Gow","year":"2013","journal-title":"Prostaglandins, Leukotrienes Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2022.102414_bib0038","unstructured":"ICD-10 International. Statistical. Classification of Diseases and. Related Health. Problems. 10th Revision. Volume 2. Instruction manual. 2010 Edition."},{"key":"10.1016\/j.plefa.2022.102414_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.plefa.2022.102414_bib0040","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.clinbiochem.2008.05.013","article-title":"Role of polyunsaturated fatty acids in the management of Egyptian children with autism","volume":"41","author":"Meguid","year":"2008","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.plefa.2022.102414_bib0041","first-page":"40","article-title":"Nutritional and metabolic biomarkers in autism spectrum disorders: an exploratory study","volume":"14","author":"Esparham","year":"2015","journal-title":"Integr. Med."},{"key":"10.1016\/j.plefa.2022.102414_bib0042","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.plefa.2009.01.007","article-title":"Plasma fatty acid profiles in autism: a case-control study","volume":"80","author":"Weist","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2022.102414_bib0043","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1476-511X-10-63","article-title":"Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia","volume":"10","author":"El-Ansary","year":"2011","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.plefa.2022.102414_bib0044","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.plefa.2006.02.001","article-title":"Fatty acid compositions of red blood cell phospholipids in children with autism","volume":"74","author":"Bu","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2022.102414_bib0045","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1017\/S0007114509992881","article-title":"The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intake","volume":"103","author":"Bell","year":"2010","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.plefa.2022.102414_bib0046","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.plefa.2009.06.003","article-title":"Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism","volume":"81","author":"Pastural","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2022.102414_bib0047","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnmol.2017.00034","article-title":"Metabolic dysfunction underlying autism spectrum disorder and potential treatment approaches","volume":"10","author":"Cheng","year":"2017","journal-title":"Front Mol. Neurosci."},{"issue":"21","key":"10.1016\/j.plefa.2022.102414_bib0048","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.lfs.2004.04.038","article-title":"Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins","volume":"75","author":"Chauhan","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.plefa.2022.102414_bib0049","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12011-010-8840-9","article-title":"Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation","volume":"143","author":"Meguid","year":"2011","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.plefa.2022.102414_bib0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000323189","article-title":"The neurobiology of lipid metabolism in autism spectrum disorders","volume":"18","author":"Tamiji","year":"2010","journal-title":"Neurosignals"},{"key":"10.1016\/j.plefa.2022.102414_bib0051","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12888-018-1868-7","article-title":"FADS1-FADS2 and ELOVL2 gene polymorphisms in susceptibility to autism spectrum disorders in Chinese children","volume":"18","author":"Sun","year":"2018","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.plefa.2022.102414_bib0052","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plefa.2004.03.008","article-title":"Essential fatty acids and phospholipase A(2) in autistic spectrum disorders","volume":"71","author":"Bell","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"4","key":"10.1016\/j.plefa.2022.102414_bib0053","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.biopsych.2006.05.007","article-title":"Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study","volume":"61","author":"Amminger","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2022.102414_bib0054","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/cap.2008.0123","article-title":"Omega 3 fatty acid treatment in autism","volume":"19","author":"Meiri","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.plefa.2022.102414_bib0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/nu9020155","article-title":"Relationship between long chain n-3 polyunsaturated fatty acids and autism spectrum disorder: systematic review and meta-analysis of case-control and randomised controlled trials","volume":"9","author":"Mazahery","year":"2017","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.plefa.2022.102414_bib0056","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1440-1754.2012.02491.x","article-title":"No evidence yet to support omega-3 fatty acids as a treatment for autism","volume":"48","author":"Williams","year":"2012","journal-title":"J. Paediatr. Child Health"},{"issue":"1","key":"10.1016\/j.plefa.2022.102414_bib0057","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13229-015-0010-7","article-title":"A randomised, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism","volume":"6","author":"Mankad","year":"2015","journal-title":"Mol. Autism"},{"key":"10.1016\/j.plefa.2022.102414_bib0058","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12955-020-01284-5","article-title":"Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review","volume":"18","author":"De Crescenzo","year":"2020","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.plefa.2022.102414_bib0059","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.0b013e318249f6a9","article-title":"Red blood cell -3 fatty acid levels and markers of accelerated brain aging","volume":"78","author":"Tan","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.plefa.2022.102414_bib0060","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3945\/jn.109.119578","article-title":"Serum phospholipid docosahexae nonic acid is associated with cognitive functioning during middle adulthood","volume":"140","author":"Muldoon","year":"2010","journal-title":"J. Nutr."},{"issue":"12","key":"10.1016\/j.plefa.2022.102414_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.03.020","article-title":"Omega-3 fatty acids and cognitive decline: modulation by ApoE(epsilon)4 allele and depression","volume":"32","author":"Samieri","year":"2011","journal-title":"Neurobio. Aging"},{"key":"10.1016\/j.plefa.2022.102414_bib0062","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1179\/1476830512Y.0000000026","article-title":"Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: a comparison of individuals with and without cognitive impairment and Alzheimer's disease","volume":"15","author":"Phillips","year":"2012","journal-title":"Nutr. Neurosci."},{"issue":"4","key":"10.1016\/j.plefa.2022.102414_bib0063","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s11357-012-9453-3","article-title":"Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly","volume":"35","author":"Titova","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.plefa.2022.102414_bib0064","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/ajcn\/80.6.1650","article-title":"Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids","volume":"80","author":"Whalley","year":"2004","journal-title":"Amer. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2022.102414_bib0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4615-4861-4_7","article-title":"The release of polyunsaturated fatty acids and their lip oxygenation in the brain","volume":"447","author":"Kim","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.plefa.2022.102414_bib0066","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0361-9230(01)00551-2","article-title":"The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects","volume":"56","author":"Carver","year":"2009","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.plefa.2022.102414_bib0067","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1471-4159.2009.06335.x","article-title":"Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function","volume":"111","author":"Cao","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plefa.2022.102414_bib0068","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuint.2015.08.014","article-title":"Essential role of docosahexaenoic acid towards development of a smarter brain","volume":"89","author":"Gharami","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.plefa.2022.102414_bib0069","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biochi.2019.01.022","article-title":"The n-3 docosapentaenoic acid (DPA): a new player in the n-3 long chain polyunsaturated fatty acid family","volume":"159","author":"Drouin","year":"2019","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.plefa.2022.102414_bib0070","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/jps.24123","article-title":"Fluoxetine potentiation of omega-3 fatty acid antidepressant effect: evaluating pharmacokinetic and brain fatty acid-related aspects in rodents","volume":"103","author":"Laino","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.plefa.2022.102414_bib0071","doi-asserted-by":"crossref","first-page":"e1242","DOI":"10.1038\/tp.2017.206","article-title":"Dietary fish, n-3 polyunsaturated fatty acid consumption, and depression risk in Japan: a population-based prospective cohort study","volume":"7","author":"Matsuoka","year":"2017","journal-title":"Transl. Psychiatry"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327822000266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327822000266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:12:05Z","timestamp":1760602325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327822000266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":71,"alternative-id":["S0952327822000266"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2022.102414","relation":{},"ISSN":["0952-3278"],"issn-type":[{"type":"print","value":"0952-3278"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma and red blood cell n3 fatty acids correlate positively with the WISC-R verbal and full-scale intelligence quotients and inversely with Conner's parent-rated ADHD index t-scores in children with high functioning autism and Asperger's syndrome","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2022.102414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102414"}}